Article3 Biotech2025
Enhanced production of methylated resveratrol in engineered
Article in 3 Biotech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Metabolic engineering of Escherichia coli for methanol-assisted resveratrol biosynthesis.Bioprocess and biosystems engineering · 2026Article
- Metabolic Engineering for Biotechnological Production of Bioactive Methylated Flavonoids and Stilbenes: Progress and Perspectives.Applied biochemistry and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Resveratrol, a prominent member of the plant-derived stilbenoid family, exhibits diverse biological and pharmaceutical activities. Its methylated derivatives possess enhanced attributes compared to the parent compound, such as improved stability and bioavailability. Although resveratrol analogs are widely used in healthcare and industrial applications, their current production relies predominantly on plant extraction, which often leads to low yields and inconsistent product quality. Microbial biosynthesis offers a promising alternative to chemical synthesis and plant-based extraction. Furthermore, gene expression regulation of engineered microbes allows cells to respond to their environment and maintain proper cellular function, which results in improved target products. In this study, we developed synthetic gene clusters comprising Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-025-04449-5.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.